文献速递创伤骨科骨质疏松与代谢性骨病

使用地舒单抗治疗骨质疏松患者出现同侧股骨多发应力性骨折一例

Multiple ipsilateral femoral stress fractures in a patient taking denosumab for osteoporosis-a case report.
PubMed 文献 · Osteoporos Int · 2020-06-20

本文报告一例74岁女性骨质疏松患者在使用地舒单抗期间发生左侧股骨三处应力性骨折,经股骨髓内钉固定后骨折愈合并恢复活动。作者指出这是首例报道地舒单抗相关同侧股骨三处应力性骨折的病例,提示对使用地舒单抗且主诉大腿或腹股沟疼痛的骨质疏松患者需高度警惕。

要点

  • 使用地舒单抗的骨质疏松患者出现大腿或腹股沟疼痛应高度怀疑非典型股骨骨折。
  • 发现非典型股骨骨折时需仔细检查并对双侧股骨进行影像学评估。
  • 本例74岁女性左侧股骨三处应力性骨折经髓内钉固定后愈合并恢复活动。

核心结论

  • 使用地舒单抗的骨质疏松患者出现大腿或腹股沟疼痛时需高度怀疑非典型股骨骨折。
  • 发现非典型股骨骨折时应仔细检查并对双侧股骨行影像学评估。

研究设计与样本

  • 病例报告:一例74岁女性骨质疏松患者在使用地舒单抗期间发生左侧股骨三处应力性骨折。

主要发现

  • 患者左侧股骨发生三处应力性骨折。
  • 经股骨髓内钉固定后骨折愈合,患者恢复活动。

临床怎么用

  • 对使用地舒单抗的骨质疏松患者主诉大腿或腹股沟疼痛时保持高度警惕。
  • 发现非典型股骨骨折时对双侧股骨进行仔细检查和影像学评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: This is the first report describing three ipsilateral femoral stress fractures in a patient taking denosumab. INTRODUCTION: Multiple reports of atypical femur fractures (AFF) in patients receiving denosumab have emerged recently. Denosumab is an anti-resorptive agent approved for treatment of osteoporosis. It is a human monoclonal antibody which blocks osteoclast activation, maturation, and function. METHODS: This is a case report of a 74-year-old female patient who sustained three stress fractures of her left femur. RESULTS: The patient healed her fractures after intramedullary nailing of the femur and was able to return to her activities. CONCLUSIONS: High index of suspicion is needed in any patient with osteoporosis on denosumab complaining of thigh or groin pain. Careful examination and radiographic studies of both femurs are warranted if AFF is discovered.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Piponov HI, Goldstein JM, Eisenberg GM, et al. Multiple ipsilateral femoral stress fractures in a patient taking denosumab for osteoporosis-a case report. Osteoporos Int. 2020. PMID: 32561954. doi:10.1007/s00198-020-05499-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。